XML 51 R36.htm IDEA: XBRL DOCUMENT v3.19.1
Stock-Based Compensation (Tables)
6 Months Ended
Mar. 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Stock-Based Compensation Expense
Stock-based compensation expense is included in the consolidated results of operations as follows (in thousands):
 
Three months ended March 31,
 
Six months ended March 31,
 
2019
 
2018
 
2019
 
2018
Cost of sales
$
25

 
$
46

 
$
80

 
$
96

Sales and marketing
466

 
391

 
819

 
725

Research and development
269

 
167

 
469

 
175

General and administrative
533

 
721

 
1,339

 
1,382

Stock-based compensation before income taxes
1,293

 
1,325

 
2,707

 
2,378

Income tax benefit
(263
)
 
(277
)
 
(557
)
 
(498
)
Stock-based compensation after income taxes
$
1,030

 
$
1,048

 
$
2,150

 
$
1,880

Schedule of Stock Option Activity
The following table summarizes our stock option activity (in thousands, except per common share amounts):
 
 
Options Outstanding
 
Weighted Average Exercised Price
 
Weighted Average Contractual Term (in years)
 
Aggregate Intrinsic Value (1)
Balance at September 30, 2018
 
3,526

 
$10.49
 
 
 
 
Granted
 
590

 
10.92
 
 
 
 
Exercised
 
(410
)
 
9.14
 
 
 
 
Forfeited / Canceled
 
(301
)
 
12.64
 
 
 
 
Balance at March 31, 2019
 
3,405

 
$10.67
 
4.3
 
$
7,154

 
 
 
 
 
 
 
 
 
Exercisable at March 31, 2019
 
2,192

 
$10.29
 
3.3
 
$
5,434

(1) The aggregate intrinsic value represents the total pre-tax intrinsic value, based on our closing stock price of $12.67 as of March 31, 2019, which would have been received by the option holders had all option holders exercised their options as of that date. The intrinsic value of an option is the amount by which the fair value of the underlying stock exceeds its exercise price.
Schedule of Valuation Assumptions
The table below shows the weighted average fair value, which was determined based upon the fair value of each option on the grant date utilizing the Black-Scholes option-pricing model and the related assumptions:
 
Six months ended March 31,
 
2019
 
2018
Weighted average per option grant date fair value
$4.36
 
$3.72
Assumptions used for option grants:
 
 
 
Risk free interest rate
2.56% - 2.93%
 
2.12% - 2.58%
Expected term
6.00 years
 
6.00 years
Expected volatility
33% - 34%
 
33% - 34%
Weighted average volatility
33%
 
33%
Expected dividend yield
0
 
0
Schedule of Nonvested Restricted Stock Units
A summary of our non-vested restricted stock units as of March 31, 2019 and changes during the six months then ended is presented below (in thousands, except per common share amounts):
 
Number of Awards
 
Weighted Average Grant Date Fair Value
Nonvested at September 30, 2018
674

 
$
11.05

Granted
534

 
$
11.60

Vested
(248
)
 
$
10.42

Canceled
(115
)
 
$
12.31

Nonvested at March 31, 2019
845

 
$
11.41